Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Nature Communications|July 15, 2024
PRC2-AgeIndex as a universal biomarker of aging and rejuvenationMahdi Moqri, Andrea Cipriano, Daniel J Simpson, et al.Molecular Cancer|July 10, 2013
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumoursAnnica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, et al.Journal for Immunotherapy of Cancer|July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina Baik, Joel W Neal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastomaDenah R Taggart, Myo M Han, Alekist Quach, et al.Genes|September 5, 2019
Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart DiseaseAlessandro Testori, Vito A Lasorsa, Flora Cimmino, et al.Disease Models & Mechanisms|October 30, 2012
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastomaDamini Chand, Yasuo Yamazaki, Kristina Ruuth, et al.Journal for Immunotherapy of Cancer|July 2, 2024
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphomaSushma Bharadwaj, Eric Lau, Mark P Hamilton, et al.Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.Journal for Immunotherapy of Cancer|December 8, 2019
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibitionJulie Voeller, Amy K Erbe, Jacob Slowinski, et al.Cancer Discovery|October 31, 2015
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyElena Sotillo, David M Barrett, Kathryn L Black, et al.Pageof 6